Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Cp (NQ: TECH )

74.81 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 74.81
Bid (Size) 61.67 (1)
Ask (Size) 84.16 (3)
Prev. Close 74.81
Today's Range 74.81 - 74.81
52wk Range 51.79 - 89.91
Shares Outstanding 157,584,637
Dividend Yield 0.43%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Demystifying Bio-Techne: Insights From 4 Analyst Reviews
Via Benzinga
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
Thanks to the underlying pertinence, these established biotech stocks to buy offer confidence to investors facing tricky market conditions. 
Via InvestorPlace

Performance

YTD
-2.48%
-2.48%
1 Month
-9.32%
-9.32%
3 Month
+4.08%
+4.08%
6 Month
-1.59%
-1.59%
1 Year
-3.38%
-3.38%

More News

Read More
5 Stocks At The Forefront Of S&P 500 ETF's Latest Rally
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
Via Benzinga
TECH Stock Earnings: Bio-Techne Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Navigating 4 Analyst Ratings For Bio-Techne
Via Benzinga
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
Via Benzinga
Earnings Outlook For Bio-Techne
Via Benzinga
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Expert Ratings for Bio-Techne
Via Benzinga
Earnings Preview: Bio-Techne
Via Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition
Via InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
Via InvestorPlace
Bio-Techne: Bolstering Investor Value with Reduced Dividends and Amplified Earnings
Via Benzinga
The 3 Best Biotech Stocks to Buy in February 2024
Via InvestorPlace
RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For February 1, 2024
Via Benzinga
3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024
Via InvestorPlace
Advancing with Stability: Bio-Techne Benefits Investors with Growing Earnings and Stable Payouts
Via Benzinga
Earnings Scheduled For October 31, 2023
Via Benzinga
3 AI Stock-Split Stocks to Buy Now
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Healthcare Stocks to Keep an Eye On
Via The Motley Fool
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
3 Healthcare Stocks That Should Be on Every Investor’s Radar This Fall
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.